Founded
Address
Other Office
285 Riverside Avenue
Suite 250
Westport, CT 06880
United States
Phone
Website
Recent investment activity
KANDO id: 30845
Corporate information
Registration country
Company type
Venture capital firm with a focus on early stage technology and healthcare companiesFunding rounds
Top investment portfolio themes
Investment activity status
Active investor
Selected investments
Displaying 151 - 175 of 242Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Active Network Inc | N/A Initial investment | |||||
Active Network Inc | Series E Initial investment | |||||
Active Network Inc | Series D Initial investment | |||||
Adlyfe | Series A | |||||
Advanced BioHealing Inc | An industry leader in the science of regenerative medicine | Series C | ||||
Advanced BioHealing Inc | An industry leader in the science of regenerative medicine | Series B | ||||
Aldea Pharmaceuticals Inc | Venture | |||||
Altheos Inc | A drug development company focused on next generation intraocular pressure (IOP) lowering agents for glaucoma and ocular hypertension. | Series A | ||||
Amicus Therapeutics Inc | N/A Initial investment | |||||
Aperto Networks Inc | WiMax equipment company. | Series F | ||||
Aperto Networks Inc | WiMax equipment company. | Series E | ||||
Aperto Networks Inc | WiMax equipment company. | Series D | ||||
Aperto Networks Inc | WiMax equipment company. | Series C | ||||
Apieron Inc | Asthma Device Monotoring Maker | Series D | ||||
Apieron Inc | Asthma Device Monotoring Maker | Series C | ||||
Arbor Networks Inc | DDoS attack prevention, network security and visibility solutions company. | N/A Initial investment | ||||
Argon Networks Inc | N/A | |||||
Associated Content Inc | Content Publishing Platform | Series C | ||||
BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series C | ||||
BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series B | ||||
BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series A | ||||
Blip Networks Inc | Owner and operator of blip.tv, an online television network, features, promotes, and monetizes shows on the web. | Series D | ||||
Blip Networks Inc | Owner and operator of blip.tv, an online television network, features, promotes, and monetizes shows on the web. | Series C | ||||
Cardlytics Inc | Series G | |||||
Cardlytics Inc | Series D |